- Open Access
Physics of pure and non-pure positron emitters for PET: a review and a discussion
© Conti and Eriksson. 2016
Received: 4 February 2015
Accepted: 31 May 2015
Published: 23 May 2016
With the increased interest in new PET tracers, gene-targeted therapy, immunoPET, and theranostics, other radioisotopes will be increasingly used in clinical PET scanners, in addition to 18F. Some of the most interesting radioisotopes with prospective use in the new fields are not pure short-range β+ emitters but can be associated with gamma emissions in coincidence with the annihilation radiation (prompt gamma), gamma-gamma cascades, intense Bremsstrahlung radiation, high-energy positrons that may escape out of the patient skin, and high-energy gamma rays that result in some e +/e − pair production. The high level of sophistication in data correction and excellent quantitative accuracy that has been reached for 18F in recent years can be questioned by these effects. In this work, we review the physics and the scientific literature and evaluate the effect of these additional phenomena on the PET data for each of a series of radioisotopes: 11C, 13N, 15O, 18F, 64Cu, 68Ga, 76Br, 82Rb, 86Y, 89Zr, 90Y, and 124I. In particular, we discuss the present complications arising from the prompt gammas, and we review the scientific literature on prompt gamma correction. For some of the radioisotopes considered in this work, prompt gamma correction is definitely needed to assure acceptable image quality, and several approaches have been proposed in recent years. Bremsstrahlung photons and 176Lu background were also evaluated.
With the rise of interest in new PET tracers, multiple-tracer PET imaging, gene-targeted therapy, theranostics, and immunoPET [1–3], other radioisotopes are expected to be increasingly used in clinical PET scanners, side by side with 18F. Some short-lived radioisotopes have been extensively used in the past in the clinic or in research: 15O and 11C for brain studies, 13N and 82Rb for cardiac studies, and 18F and 11C for several applications in oncology. 68Ga use is showing a dramatic growth because of the applicability in labeling both small compound and macromolecules and because it is obtained from a relatively inexpensive 68Ge/68Ga generator system .
The use of monoclonal antibodies (mAb) as therapeutic target-specific agents has generated an interest in PET labeling of mAb [5, 6]. In order to better match the slower pharmacokinetics of the mAb, radioisotopes with a long half-life, such as 64Cu, 76Br, 86Y, 89Zr, and 124I, are more apt to follow the tracer and the radiopharmaceutical for hours, days, or even weeks [7, 8].
Moreover, the same radioisotopes are particularly suitable for the development of molecular imaging in tandem with a therapeutic agent, pharmaceutical or radiotherapeutic (also known as theranostics), for personalized treatment planning or real-time therapy monitoring. For example, 86Y and 124I can be used as a surrogate of 90Y and 131I, β− emitters commonly adopted in radiotherapy, in order to accurately estimate the most likely dose distribution before radiotherapy . Recently, it has been shown that 90Y can simultaneously work as an imaging agent and a therapeutic agent .
Finally, PET imaging with multiple tracers could be instrumental to better understand the molecular basis of a disease: multiple aspects of the disease can be characterized in the same study, and this would also allow for avoiding multiple scans, with cost reduction and improved patient comfort . PET radioisotopes could be identified by different half-lives and also by their different decay mechanisms. In particular, a compound labeled with a pure positron emitter, as 18F, can be used together with another compound labeled with a radioisotope with a prompt gamma in coincidence with the positron decay, as 124I or 86Y: using the differential count rates of dual and triple coincidences can allow for differentiating and reconstructing the individual radioisotope activities [11–13].
Some of the most interesting radioisotopes with prospective use in the new fields are not pure short-range β+ emitters but can be associated with gamma emissions in coincidence with the annihilation radiation (prompt gamma), gamma-gamma cascades, intense Bremsstrahlung radiation, high-energy positrons that may escape out of the patient skin, and high-energy gamma rays that result in some e +/e − pair production. The high level of sophistication in data correction and excellent quantitative accuracy that has been reached for 18F in recent years can be questioned by these effects. In this work, we review the physics and the scientific literature and evaluate the effect of these additional phenomena on the PET data for each of a series of radioisotopes: 11C, 13N, 15O, 18F, 64Cu, 68Ga, 76Br, 82Rb, 86Y, 89Zr, 90Y, and 124I. In addition, some experimental results are analyzed, using data from work previously published, or data ad hoc acquired for this article, in order to characterize the different phenomena.
Prompt gamma emitted in coincidence with β+, within the energy window of the PET scanner
High-energy prompt gammas that fall within the energy window of the scanner after scatter in the patient
High-energy gammas generating e +/e − pair production in the tissue or in the high Z detectors
High-energy positrons escaping the patient skin and annihilating in the scanner tunnel
Radiation and coincidences from 176Lu or other radioactive impurities in the scintillator
The decay schemes of the radioisotopes of interest have been studied and are available through several reference web sites [14–16]. These are presented in simplified form in the Additional file 1 as a convenient summary for the reader. Radioisotope half-life, branching ratio, and photon and positron energies, reported in this article in the “Pure PET radioisotopes” and “PET radioisotopes with relevant contribution of prompt gammas” sections, are from the same sources. The positron ranges in water, as a surrogate of human tissue, are from the National Institute of Standards and Technology web site .
Short or long half-life: the former is typically convenient for high-statistics PET scan of compounds that reach their target very quickly, like 15O in brain studies or 18F-FDG for oncology; the latter is used where the target is reached more slowly, as in 89Zr-labeled or 64Cu-labeled antibody imaging.
Energy of the positron: the energy determines the range in the tissue. Better spatial resolution can be reached with short-range positrons; 11C, 18F, 64Cu, and 89Zr are typical short-range positron emitters, and 13N, 15O, 68Ga, 82Rb, and 124I are long-range positron emitters (>1 mm).
Prompt gamma contamination: gammas emitted in decay cascades with the positron emission produce spurious coincidences, which blur the PET image and produce quantification errors, as in 76Br, 86Y, 82Rb, and 124I.
Emission of high-energy β− decay: some radioisotopes have an alternative high-energy β− decay that could be used for radiotherapy, and the minority β+ decay could be used for online monitoring or dosimetry of the radiotherapy, as in 64Cu or 90Y; others have a homologous radioisotope used for radiotherapy, and the β+ emitter can be used for treatment planning of the β− emitter, as in 131I (β− emitter) and 124I (β+ emitter).
For the sake of simplicity, we will organize the radioisotopes in terms of pure positron emitter and prompt gamma positron emitters. A special class will be dedicated to 90Y. A preliminary section is dedicated to a short review of the effect of positron range on spatial resolution and methods to correct for this effect.
Effect of positron range on spatial resolution
Many of the PET radioisotopes suitable for immunoPET and theranostics emit positron with long positron range. This implies a blurring of the source distribution and a consequent loss of spatial resolution [17–19]. The loss of spatial resolution, compared to short-range positron emitter such as 18F, has been measured in high-resolution PET scanners for brain imaging and animal PET [20, 21]. For the present generation of commercial whole-body PET scanners, with spatial resolution of about 4 mm, the blurring due to positron range is barely measurable . Nevertheless, in the future, even whole-body PET, with improved spatial resolution, might require a mechanism to recover the loss of resolution associated with long positron range.
An accurate characterization of the point spread function (PSF) allows for compensation of the loss in contrast recovery using calculated spill-over and partial volume corrections . Methods to correct for positron range have been presented, as deblurring techniques  or incorporating positron range in the reconstruction itself . Other researchers used the Monte Carlo simulation to estimate the distance between the source position and the detection line of response in the PET scanner and then incorporated this information in the reconstruction [19, 26]. The increasing use of these long-positron-range radioisotopes will make methods for resolution recovery even more necessary.
In addition, the long positron range of some of these radioisotopes can not only blur the primary radioisotope distribution but can also generate image artifacts. The positrons can exit the target organs and travel in air annihilating in a location where there is no tracer uptake, generating “ghost” uptake. This phenomenon has been observed in the trachea and in the larynx when 124I and 68Ga are used [27, 28], but it could also be present in low-density organs such as the lungs, especially in PET/MR systems where the positrons may follow the direction of the magnetic field.
Pure PET radioisotopes
Branching (β+) in %
E max (MeV)
E mean (MeV)
R max (mm)
R mean (mm)
11C decays into 11B with a half-life t 1/2 = 20.4 min. The decay is 99.8 % by β+ and 0.2 % by electron capture (EC, no radiation emitted). The emitted positron has 0.960-MeV maximum energy (E max) and 0.386-MeV mean energy (E mean), which corresponds to a 4.2-mm maximum range in water (R max) and a 1.2-mm mean range in water (R mean).
13N decays into 13C with a half-life t 1/2 = 10.0 min. The decay is 99.8 % by β+ and 0.2 % by EC (no radiation emitted). The emitted positron has E max = 1.199 MeV and E mean = 0.492 MeV, which corresponds to a R max = 5.5 mm and a R mean = 1.8 mm.
15O decays into 15N with a half-life t 1/2 = 2.0 min. The decay is 99.9 % by β+ and 0.1 % by EC (no radiation emitted). The emitted positron has E max = 1.732 MeV and E mean = 0.735 MeV, which corresponds to a R max = 8.4 mm and a R mean = 3.0 mm.
18F decays into 18O with a half-life t 1/2 = 110 min. The decay is 96.9 % by β+ and 3.1 % by EC (no radiation emitted). The emitted positron has E max = 0.634 MeV and E mean = 0.250 MeV, which corresponds to a R max = 2.4 mm and a R mean = 0.6 mm.
64Cu decays, with a half-life t 1/2 = 12.7 h, either β− into 64Zn (38.5 %, with E max = 0.579 MeV) or into 64Ni (61.5 %) via a combination of EC and β+. The EC has a branching ratio of 43.5 %, while the β+ decay is 17.5 %. The emitted positron has E max = 0.653 MeV and E mean = 0.278 MeV, which corresponds to a R max = 2.5 mm and a R mean = 0.7 mm.
89Zr decays into a metastable-state 89mY, with a half-life t 1/2 = 78.4 h. The decay is 22.7 % by β+ and 76.2 % by EC. The rest (1.1 %) of 89Zr decays by EC into several excited levels of 89Y, followed by emission of γs into the same metastable-level 89mY. The emitted positron has E max = 0.902 MeV and E mean = 0.396 MeV, which corresponds to a R max = 3.8 mm and a R mean = 1.3 mm. The metastable-level 89mY decays (t 1/2 = 16 s) to a ground-state 89Y by emission of a γ (0.909 MeV). Because of the long half-life of this metastable-level 89mY, the γ is in cascade with β+ but cannot be considered in coincidence and it does not behave as a prompt gamma.
PET radioisotopes with relevant contribution of prompt gammas
Properties of prompt gamma positron emission radioisotopes. Only the positrons and prompt gammas with the two highest branching ratios are listed. Data from the National Institute of Standards and Technology , Laboratoire National Henri Becquerel , and Brookhaven National Laboratory 
Branching (β+) in %
β+ E max (MeV)
Branching (γ) in %
γ E (PG) (MeV)
68Ga decays into 68Zn, with a half-life t 1/2 = 67.8 min. The decay is 88.9 % by β+ and 11.1 % by EC. The main β1 + decay (87.7 %) is to the ground level of 68Zn (E max = 1.899 MeV, E mean = 0.836 MeV, R max = 9.2 mm, R mean = 3.5 mm), and it is a pure positron emission branch. A small fraction decays β2 + (1.2 %) into an excited level of 68Zn, which promptly (t 1/2 = 1.6 ps) decays into the ground level with a γ1 (1.077 MeV). This can constitute a small prompt gamma contamination in the PET data, if the 1.077-MeV γ1 has a scatter interaction in the patient, and generates a detectable lower energy γ in coincidence with the positron annihilation pair. The principal EC branches are to the ground level (8.9 %) or to the first excited level (1.8 %). The rest of the EC (0.4 %) decays are into short-life excited levels emitting γs of various energies (0.227–2.821 MeV), with negligible probability to be detected in coincidence.
76Br decays into 76Se, with a half-life t 1/2 = 16.2 h. The decay is 54.8 % by β+ with different energies and 45.2 % by EC. The only pure positron emitter decay β3 + decays to the ground level of 76Se with a branching ratio of only 6.0 %. The other major β+ decay modes populate an excited level of 76Se, with emission of cascades of prompt gammas: β1 +, β2 +, and β4 + (25.8, 6.3, and 5.2 %, respectively) and a large number of other β+ decays that add up to 11.5 %. Most β+s are in cascade with a prompt gamma γ1, with energy (0.559 MeV) very close to the typical PET energy window. In summary, about 90 % of 76Br positrons are associated with one or more prompt gammas. A large fraction of prompt gammas has energy within the PET energy window; a smaller fraction of the high-energy gammas could scatter in the patient and produce photons also within the PET energy window; and others can directly generate e +/e − pairs. The energy of the β+ is typically high, with a long range and resulting in poor spatial resolution.
82Rb decays into 82Kr, with a half-life t 1/2 = 1.3 min. The decay is β+ with two main energies. The pure positron decay β1 + is to the ground level of 82Kr, with a branching ratio of 81.8 % (E max = 3.378 MeV, E mean = 1.535 MeV, R max = 17.0 mm, R mean = 7.1 mm). The second most frequent positron decay β2 + is to an excited level of 82Kr, with a branching ratio of 13.1 % (E max = 2.601 MeV, E mean = 1.168 MeV, R max = 13.0 mm, R mean = 5.0 mm). As a consequence, a prompt gamma γ1, with energy 0.777 MeV, is emitted in cascade, generating prompt gamma coincidences, mainly after scatter in the patient body. Both β1 + and β2 + have high energy and consequently long ranges.
86Y decays into 86Sr, with a half-life t 1/2 = 14.7 h. The decay is 31.9 % by β+ with different energies and 68.1 % by EC. All β+ decay modes populate excited levels of 86Sr, with emission of cascades of prompt gammas. The main β+ decay modes are β1 + (11.9 %, E max = 1.221 MeV, E mean = 0.535 MeV, R max = 5.6 mm, R mean = 1.9 mm), in cascade with γ5 (1.920 MeV) and γ1 (1.077 MeV); β2 + (5.6 %, E max = 1.545 MeV, E mean = 0.681 MeV, R max = 7.1 mm, R mean = 2.8 mm), in cascade with γ7 (0.443 MeV), γ3 (1.153 MeV), and γ1 (1.077 MeV); and β3 + (3.6 %, E max = 1.988 MeV, E mean = 0.883 MeV, R max = 9.7 mm, R mean = 3.7 mm), in cascade with γ3 (1.153 MeV) and γ1 (1.077 MeV). Even non-β+ decays generate cascades of gammas in coincidence. All gamma cascades can generate spurious coincidences: some prompt gammas have energy within the PET energy window. Part of the high-energy gammas could scatter in the patient and produce photons also within the PET energy window, and others can directly generate e +/e − pairs. The energy of the β+ is typically high, with a long range and with degraded spatial resolution.
124I decays into 124Te, with a half-life t 1/2 = 100.2 h. The decay is 77.3 % by EC and 22.7 % by β+ with two main modes: a pure positron decay to the ground level of 124Te, β2 + (10.7 %, E max = 2.138 MeV, E mean = 0.975 MeV, R max = 10.0 mm, R mean = 4.4 mm), and a β1 + mode (11.7 %, E max = 1.535 MeV, E mean = 0.687 MeV, R max = 7.1 mm, R mean = 2.8 mm), which decays into an exited state of 124Te, with a prompt gamma emission γ1 (0.602 MeV). There is an additional β3 + (0.3 %, E max = 0.812 MeV, E mean = 0.367 MeV, R max = 3.4 mm, R mean = 1.1 mm), with a prompt gamma emission γ3 (0.723 MeV), also in cascade with emission γ1 (0.602 MeV). Moreover, a large part of the excited level is populated by EC decays via gamma cascades into the first excited level of 124Te that decays into the ground level with the same γ1 (602 MeV), and they can produce coincidences between γ1 and photons in the cascade. Some gammas have energy within the PET energy window. A fraction of the high-energy gammas could undergo Compton scatter in the tissue, and the scattered photons might enter the PET energy window. Other high-energy gammas can directly generate e +/e − pairs. The energies of the β+ are high, associated with a long range and poor spatial resolution.
90Y, a non-β+ decay PET radioisotope
90Y is mainly a β− emitter used for radiotherapy and associated with very high Bremsstrahlung radiation but has a very small branching ratio that produces e +/e − pairs, a weak but viable PET signal .
90Y decays (t 1/2 = 64.1 h) 99.99 % into the ground-level 90Zr by β1 − (2.280 MeV) and 0.0115 % into an excited level of 90Zr by β2 − (0.519 MeV). The high-energy β1 − is used for radiotherapy, and the fast electrons of β1 − emit strong Bremsstrahlung radiation. The excited level associated with β2 − decays into a ground state of 90Zr by internal conversion (0.0083 %) or creation of an e +/e - pair (0.0032 %) . This small branching ratio in the e +/e - pair annihilates and can be observed as a PET signal. The e +/e - pair can have a maximum total kinetic energy of 0.739 MeV; therefore, it has a short range.
Prompt gamma characterization
PET data reconstruction is based on a two-step process: estimating the corrections to the data and image reconstruction itself. The data corrections are normalization (individual detector sensitivity, sensitivity profile differences due to radial position of the source, and other factors relative to the scanner geometry), attenuation correction (due to the interaction of emitted photons with the patient tissue), random correction (accidental coincidence of uncorrelated photons at a high count rate), and scatter correction (photons having a Compton interaction in the patient and therefore changing energy and direction). Typically, all corrections assume that only two back-to-back 511-keV photons from positron annihilation are involved: individual detector sensitivity is measured with 511-keV photons, attenuation correction is measured with CT X-rays but is converted into a 511-keV attenuation coefficient, and scatter is simulated or estimated based on single (or multiple) scatter simulations or models of interaction of 511-keV photons. Randoms are usually estimated using a delayed window or from single models, measuring single count rates in detector. Because of this, the random estimate does not include any assumption about the energy or the direction of the detected photons, and a random estimate method can work with any radioisotope.
Most clinical applications of PET require 18F-FDG PET imaging. Tracers based on 18F are pure β+ emitters, and only 511 keV is emitted. Moreover, 18F’s positrons have a short range (<1 mm), and the position of the radioisotope can be approximated with the position of the positron annihilation. As we discussed in the previous section, also 11C, 13N, and 15O are pure positron emitters. Because of the longer range of 13N and 15O, those radioisotopes might result in slightly blurred images or require positron range deblurring. 64Cu and 89Zr can be considered pure β+ emitters, even though they have a much lower branching ratio: 64Cu decays β+ to the ground level of 64Ni, and 89Zr decays β+ to a metastable level of Yttrium 89mY, but the long half-life of the metastable level (15.8 s) makes the associated gamma not in coincidence.
Finally, radioisotopes with a prompt gamma can generate not only coincidences between two photons but also triple coincidences, between two annihilation gammas and a prompt gamma. The fraction of triple coincidences has been estimated to be about 25 % for 124I and greater than 50 % for 86Y . The different ratios of double and triple coincidences in pure beta emitter and non-pure beta emitter have been exploited as a method to differentiate radioisotopes in multiple-tracer imaging [12, 13].
In fact, 68Ga has only 1.2 % of β+ to an excited level, associated with a 1.077-MeV γ, compared to 87.7 % of β+ to the ground level. And the prompt gamma contribution to coincidences is even lower because the γ has to scatter and reduce its energy to be detected. Nevertheless, it has been observed that if the 68Ga activity is concentrated in a specific organ, and the scatter is evaluated away from the concentrated activity, this small background of the prompt gamma can create artifacts and generate scatter overestimate. In these occurrences, it has been recommended to use some prompt gamma correction even for 68Ga .
82Rb, used for cardiac studies, has a higher prevalence of the prompt gamma, 13.1 % of β+ to an excited level, associated with a 0.777-MeV γ, compared to 81.8 % of β+ to the ground level. The detection probability of the prompt gamma is reduced by the fact that only a small fraction of the 0.777-MeV γs falls into the energy window (typically, the upper threshold is between 550 and 650 keV) and another fraction enters the window only after scattering in the tissue. In any case, a prompt gamma correction is absolutely necessary for 82Rb.
For both 82Rb and 68Ga, a uniform radial offset or a first-order polynomial well describe the prompt gamma, probably because the scattered detected gammas have quite a flat spatial distribution.
Finally, 76Br and 86Y are dominated by decay schemes with prompt gammas. For 76Br, the largely dominant main β+ decay (25.8 %) is associated with a 0.559-MeV γ; in addition, other decay modes are characterized by γ cascades. In the 86Y, all the dominant β+ decays (11.9, 5.6, and 3.6 %) are associated with a 1.077-MeV γ; in addition, other decay modes terminate into the same 1.077-MeV level. Prompt gamma correction is absolutely necessary, since spurious coincidences are the majority of the coincidences for these radioisotopes.
Prompt gamma correction
Standard scatter correction and random correction alone are not sufficient to obtain quantitative images in the presence of abundant spurious coincidences from prompt gammas. In the absence of proper correction, this results in high artifact background levels and consequent loss of contrast, or overestimation of the conventional scatter, with over subtraction in the central part of the body. In order to mitigate the effect of the prompt gamma, it has been shown that a narrower energy window can effectively reduce the prompt gamma contamination in the data . This alone does not eliminate the problem, particularly in situations where the prompt gammas have energy very close to the conventional PET energy (511 keV) or the prompt gamma coincidences are the majority component. Moreover, it does reduce the sensitivity of the PET scanner to true coincidences. A new correction is needed, the prompt gamma correction (PGC). In the past years, several methods have been proposed to estimate and subtract the prompt gamma component.
The first group of methods consists of estimating the prompt gamma background fitting the radial tails of the sinogram with a constant offset and first- or second-order polynomials. At the radial extremities of the sinogram, no source of activity is present, the single or multiple scatter of 511 keV from positron annihilation is negligible. The offset due to prompt gammas can be evaluated and subtracted. Subtracting a simple uniform background has been shown to be effective even with 86Y and 124I, which have abundant prompt gamma fraction [34–36]. A linear approximation of the background has been used successfully for 76Br and proposed in general for all prompt gamma radioisotopes [37–39]. In order to better match the slightly concave shape of the background observed in 86Y and 124I , a second-order polynomial fit to the tails has been proposed (and tested on 86Y) .
A second approach is based on the observation that, for 82Rb, the prompt gamma background has a similar radial distribution as the randoms . The authors proposed a method that uses the scaled random estimate, added to the single scatter conventional estimate, to match the tails of the prompt sinogram. The random scaling factor, obtained by fitting the tails, includes the prompt gamma contribution. This approach to prompt gamma correction was also used on 124I data, where the 124I image quality after PGC was comparable to that shown in a similar experiment with 18F .
A third approach is based on a convolution of the estimate of the original activity with some kernel based on models that include prompt gamma generation. One option uses a spatially variant, attenuation-dependent kernel that has been analytically determined and is based upon a simplified model of the cascade-coincidence attenuation and detection process . The model is based on the measured attenuation map of the patient. In this method, the emission sinogram is preliminarily corrected with the standard corrections, then convolved with the kernel, and the tails of the convolved sinogram and the measured sinogram are fitted to obtain a scaling factor for the convolution kernel. Then, the scaled kernel can be used for the final estimate of the prompt gamma correction. This method has been tested with 76Br and 86Y data. Another group proposed a correction method for 86Y, based on the convolution of the estimate of the original activity with a 86Y point spread function kernel . The resulting prompt gamma estimate is then normalized to counts outside the patient body, in order to obtain a more accurate correction. The method can be iterated. The 86Y point spread function kernel was measured once with an elliptical phantom that simulates the abdomen. Even with its limitation (the point spread function is based on a phantom), the results are encouraging.
A fourth approach is based on a simple attenuation model (SAM) for prompt gammas , analog to the single scatter model for single scatter simulation (SSS) . This method assumes that the principal effect driving the spatial distribution of the prompt gamma coincidences in 124I is the simple attenuation of the 0.603 MeV in the patient body. The attenuation probability, for each source position and each detector, is computed geometrically, based on the expected travel path in the patient. As for the SSS, the original emission sinogram and the measured attenuation map of the patient are used to estimate a first approximation of the activity distribution. At each iteration, the attenuation of the prompt gammas is estimated via the new SAM method and the scatter of the annihilation photons via the conventional SSS. This method has shown excellent matching of the radial shape for 124I .
Finally, a possible but time-consuming solution is a full Monte Carlo simulation of the emission and interaction of all radiation in the prompt gamma radioisotopes. Fast-simulation packages for PET like SimSET have been used . GATE Monte Carlo simulation was successful for a complete simulation of non-pure radioisotopes, and it was used as a support for estimating suitable functions modeling the tails of the sinograms. In particular, a two-component correction was proposed with the aid of GATE simulations, a uniform background and a Gaussian function [47, 48].
Additional sources of spurious coincidences: positron range, Bremsstrahlung X-rays, LSO background
High-energy positrons, associated with ranges larger than a few millimeters, can escape the patient skin. The positrons can travel in air and reach the PET scanner internal tunnel, where they annihilate and produce two 511-keV gammas in coincidence, completely uncorrelated with the distribution of the radioisotope in the patient (Fig. 4a). This effect might be present in β+ emitters with a high branching ratio for high-energy positrons: 68Ga (87.7 % of β+ with R max = 9.2 mm and R mean = 3.5 mm), 76Br (25.8 % of β+ with R max = 17.4 mm and R mean = 7.1 mm), 82Rb (81.8 % of β+ with R max = 17.0 mm and R mean = 7.1 mm), 86Y (with most of β+ with R max between 5 and 15 mm), and 124I (11.7 % of β+ with R max = 7.1 mm and R mean = 2.8 mm and 10.7 % of β+ with R max = 10.0 mm and R mean = 4.4 mm).
In addition, sources of radioactivity completely independent of the patient can generate a background radiation: for example, in LSO- or LYSO-based PET scanners, a small background of 176Lu radiation can be seen when the PET signal in the patient is extremely low, as in 90Y imaging. LSO contains 2.6 % of 176Lu, a radioactive isotope that decays β− into 176Hf with a cascade of γ photons in coincidence, with 307-, 202-, and 88-keV energies. A coincidence of a β− in a detector and two photons (307 keV + 202 keV) in another is unlikely but possible (Fig. 4b). The 176Lu β− in a detector generates about 5000 single counts per second per block or a total random counts of about 1100 s−1 in a four-ring Biograph mCT [49, 50]. This is a small but not negligible background for some applications at a very low count rate, such as with 90Y imaging. On the other hand, it has been demonstrated that randoms can be properly measured and corrected using standard random correction, even for 90Y imaging . From the point of view of net true coincidence rate, after random subtraction, about 1 to 5 total count/s have been measured in the same four-ring LSO-based mCT when no source was present [49, 50].
In the presence of very high activity, high-energy β− or β+ can produce Bremsstrahlung radiation (Fig. 4c). Generally, a few thousands of MBq of 90Y are injected in the patients, and the 99.98 % of high-energy β−s from the decay produce a very high flux of Bremsstrahlung X-rays, which have a broad spectrum with endpoint 2.279 MeV. They can reach the detectors and produce e +/e − pairs and therefore annihilation photons. Some authors propose this as an explanation for the low background tails as seen in Fig. 7 .
All the possible phenomena (LSO background, Bremsstrahlung X-rays) add up to a small net true contribution that still need to be properly considered for 90Y imaging, given the extremely low 90Y branching ratio of the e +/e − pair production [52, 53]. Nevertheless, even with a background of singles, randoms, and net trues, LSO and LYSO scanners have been proven to function better than BGO-based scanners because of the time-of-flight capability associated with fast LSO/LYSO scintillators . In general, the extremely small background of net true coincidences is neglected, and no additional correction, apart from standard scatter and random corrections, is performed for 90Y imaging in the commercial PET scanners.
With the foreseeable growth of the use of PET beyond conventional 18F-FDG oncology, PET scanner performance needs to be characterized with a wider range of radioisotopes that are not all pure β+ emitters. In this article, we reviewed the physics of several most used or most promising radioisotopes, with focus on the features that can generate artifacts or challenges to the image reconstruction. In particular, we discussed the present complications arising from the so-called prompt gammas, and we reviewed the limited scientific literature on prompt gamma correction. The effect of high positron range, Bremsstrahlung photons, and 176Lu background were also evaluated.
We thank Thomas Carlier, David Townsend, and Therese Sjöholm for providing the phantom data, Stephan Walrand for the useful discussions on the Bremsstrahlung contribution to background counts, and Jorge Gomez del Campo for his thoughtful comments and advise.
Both authors participated equally in performing the review and writing the manuscript. Both authors read and approved the final manuscript.
The authors declare they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Van Dongen GAMS, Visser GWM, Lub-De Hooge MN, De Vries EG, Perk LR. Immuno-PET: a navigator in monoclonal antibody development and applications. Oncologist. 2007;12:1379–89.View ArticlePubMedGoogle Scholar
- Verel I, Visser GW, van Dongen GA. The promise of immuno-PET in radioimmunotherapy. J Nucl Med. 2005;46(suppl):164S–71S.PubMedGoogle Scholar
- Zalutsky MR. Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning. Clin Cancer Res. 2006;12:1958–60.View ArticlePubMedGoogle Scholar
- Velikyan I. Prospective of 68Ga-radiopharmaceutical development. Theranostics. 2014;4:47–80.View ArticleGoogle Scholar
- Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol. 2008;9:423–30.View ArticlePubMedGoogle Scholar
- Lövqvist A, Humm JL, Sheikh A, et al. PET imaging of 86Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between 86Y and 111In radiolabels. J Nucl Med. 2001;42:1281–7.PubMedGoogle Scholar
- Vallabhajosula S, Solnes L, Vallabhajosula B. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? Semin Nucl Med. 2011;41:246–64.View ArticlePubMedGoogle Scholar
- Belov VV, Bonab AA, Fischman AJ, et al. Iodine-124 as a label for pharmacological PET imaging. Mol Pharmaceutics. 2011;8:736–47.View ArticleGoogle Scholar
- Bockisch A. Matched pairs for radionuclide-based imaging and therapy. Eur J Nucl Med Mol Imaging. 2011;38 Suppl 1:S1–3.View ArticlePubMedGoogle Scholar
- Lhommel R, van Elmbt L, Goffette P, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging. 2010;37(9):1654–62.View ArticlePubMedGoogle Scholar
- Kadrmas DJ, Hoffman JM. Methodology for quantitative rapid multi-tracer PET tumor characterizations. Theranostics. 2013;3:757–73.View ArticlePubMedPubMed CentralGoogle Scholar
- Andreyev A, Celler A. Dual-isotope PET using positron-gamma emitters. Phys Med and Biol. 2011;56:4539–56. Bockisch A: Matched pairs for radionuclide-based imaging and therapy. Eur J Nucl Med Mol Imaging 2011, 38(Suppl 1):S1–S3.View ArticleGoogle Scholar
- Miyaoka RS, Hunter WCJ, Andreyev A, Pierce L, Lewellen TK, Celler A, Kinahan PE. Dual-radioisotope PET data acquisition and analysis. IEEE Nucl Sci Conf Rec. 2011:3780–3Google Scholar
- National Institute of Standards and Technology: http://www.nist.gov/. Accessed 15 Jan 2016.
- Laboratoire National Henri Becquerel: http://laraweb.free.fr/. Accessed 15 Jan 2016.
- Brookhaven National Laboratory: www.nndc.bnl.gov/nndc/nudat. Accessed 15 Jan 2016.
- Levin CS, Hoffman EJ. Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. Phys Med Biol. 1999;44:781–99.View ArticlePubMedGoogle Scholar
- Laforest R, Liu X. Image quality with non-standard nuclides in PET. Q J Nucl Med Mol Imaging. 2008;52:151–8.PubMedGoogle Scholar
- Jødal L, Le Loirec C, Champion C. Positron range in PET imaging: non-conventional isotopes. Phys Med Biol. 2014;59:7419–34.View ArticlePubMedGoogle Scholar
- De Jong HWAM, Perk L, Visser GWM, Boellaard R, van Dongen GAMS, Lammertsma AA. High resolution PET imaging characteristics of 68Ga, 124I and 89Zr compared to 18F. IEEE Nucl Sci Conf Rec. 2005;3:1624–7.Google Scholar
- Disselhorst JA, Brom M, Laverman P, et al. Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. J Nucl Med. 2010;51:610–7.View ArticlePubMedGoogle Scholar
- Soderlund AT J, Chaal JS, Tjio G, Totman J, Conti M, Townsend D. Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application - 18F, 11C, 89Zr, 124I, 68Ga, and 90Y. J Nucl Med. 2015;56(8):1265–91.View ArticleGoogle Scholar
- Liu X, Laforest R. Quantitative small animal PET imaging with nonconventional nuclides. Nucl Med Biol. 2009;36:551–9.View ArticlePubMedGoogle Scholar
- Derenzo SE. Mathematical removal of positron range blurring in high-resolution tomography. IEEE Trans Nucl Sci. 1986;33:565–9.View ArticleGoogle Scholar
- Kotasidis FA, Angelis GI, Anton-Rodriguez J, Matthews JC, Reader AJ, Zaidi H. Isotope specific resolution recovery image reconstruction in high resolution PET imaging. Med Phys. 2014;41:052503,1–11.Google Scholar
- Jødal L, Le Loirec C, Champion C. Positron range in PET imaging: an alternative approach for assessing and correcting the blurring. Phys Med Biol. 2012;57:3931–43.View ArticlePubMedGoogle Scholar
- Kolb A, Sauter AW, Eriksson L, Vandenbrouke A, Liu CC, Levin C, Pichler BJ, Rafecas M. Shine-through in PET/MR imaging: effects of the magnetic field on positron range and subsequent image artifacts. J Nucl Med. 2015;56:951–4.View ArticlePubMedGoogle Scholar
- Abdul-Fatah SB, Zamburlini M, Halders SGEA, Brans B, Teule GJJ, Kemerink GJ. Identification of a shine-through artifact in the trachea with 124I PET/CT. J Nucl Med. 2009;50:909–11.View ArticlePubMedGoogle Scholar
- Selwyn RG, Nickels RJ, Thomadsen BR, Dewerd LA, Micka JA. A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot. 2007;65:318–27.View ArticlePubMedGoogle Scholar
- Cal-González J, Lage E, Herranz E, Vicente E, Udias JM, Moore SC, Park MA, Dave SR, Parot V, Herraiz JL. Simulation of triple coincidences in PET. Phys Med Biol. 2015;60:117–36.View ArticlePubMedGoogle Scholar
- Hong I, Rothfuss R, Michel C, Casey M. Prompt gamma correction on Ga-68 PSMA PET studies. San Diego, California: presented at Nucl Sci Symp and Med Imag Conf; 2015.Google Scholar
- Hong I, Rothfuss R, Michel C, Casey M. The novel method of prompt gamma correction on I-124 PET study. San Diego, California: presented at Nucl Sci Symp and Med Imag Conf; 2015.Google Scholar
- Gregory RA, Claire A, Hooker CA, Partridge M, Flux GD. Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET/CT system. Eur J Nucl Med Mol Imaging. 2009;36:1037–48.View ArticlePubMedGoogle Scholar
- Pentlow KS, Finn RD, Larson SM, Erdi YE, Beattie BJ, Humm JL. Quantitative imaging of yttrium-86 with PET. The occurrence and correction of anomalous apparent activity in high density regions. Clin Positron Imaging. 2000;3(3):85–90.View ArticlePubMedGoogle Scholar
- Buchholz H, Herzog H, Foerster G, Reber H, Nickel O, Roesch F, Bartenstein P. PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background. Eur J Nucl Med Mol Imaging. 2003;30:716–20.View ArticlePubMedGoogle Scholar
- Surti S, Scheuermann R, Karp JS. Correction technique for cascade gammas in I-124 imaging on a fully-3D, time-of-flight PET scanner. IEEE Trans Nucl Sci. 2009;56(3):653–60.View ArticlePubMedPubMed CentralGoogle Scholar
- Lubberink M, Janssen F, Schneider H, Bergstrom M and Lundqvist H: Correction for gamma radiation from non-pure positron emitters in positron emission tomography Future Directions in Nuclear Medicine Physics and Engineering (Chicago, 21–23 March 1999) (Chicago: The University of Chicago)Google Scholar
- Lubberink M, Schneider H, Bergström M, Lundqvist H. Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET. Phys Med Biol. 2002;47(19):3519–34.View ArticlePubMedGoogle Scholar
- Sandstrom M, Tolmachev V, Kairemo K, Lundqvist H, Lubberink M. Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT. Phys Med Biol. 2004;49:5419–32.View ArticlePubMedGoogle Scholar
- Kull T, Ruckgaber J, Weller R, Reske S, Glatting G. Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode. Cancer Biother Radiopharm. 2004;19(4):482–90.View ArticlePubMedGoogle Scholar
- Watson CC, Hayden C, Casey ME, Hamill J, Bendriem B. Prompt gamma correction for improved quantification in 82Rb PET. J Nucl Med. 2008;49:64P.View ArticleGoogle Scholar
- Preylowski V, Schlögl S, Schoenahl F, Joerg G, Samnick S, Buck AK, Lassmann M. Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas? PLoS ONE. 2013;8(8):e71729.View ArticlePubMedPubMed CentralGoogle Scholar
- Beattie BJ, Finn RD, Rowland DJ, Pentlow KS. Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays. Med Phys. 2003;30:2410–23.View ArticlePubMedGoogle Scholar
- Walrand S, Jamar F, Mathieu I, Camps J, Lonneux M, Sibomana M, Labar D, Michel C, Pauwels S. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. Eur J Nucl Med. 2003;30:354–61.View ArticleGoogle Scholar
- Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci. 2000;47:1587–94.View ArticleGoogle Scholar
- Zhu X, El Fakhri G. Monte Carlo modeling of cascade gamma rays in 86Y PET imaging: preliminary results. Phys Med Biol. 2009;54:4181–93.View ArticlePubMedPubMed CentralGoogle Scholar
- Sauerzapf S, Thomas L, Behe M, Weber W, Zakhnini A, Pietrzyk U, Mix M. Using Monte-Carlo simulations to implement corrections for 1–124 as a non-pure positron emitter in small animal and human PET imaging. IEEE Nucl Sci Conf Rec. 2011:2688–2692Google Scholar
- Harzmann S, Braun F, Zakhnini A, Weber WA, Pietrzyk U, Mix M. Implementation of cascade gamma and positron range corrections for I-124 small animal PET. IEEE Trans Nucl Sci. 2014;61:142–53.View ArticleGoogle Scholar
- Carlier T, Eugene T, Bodet-Millin C, Garin E, Ansquer C, Rousseau C, Ferrer L, Barbet J, Schoenahl F, Kraeber-Bodere F. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. Eur J Nucl Med Mol Imaging Res. 2013;3:11.Google Scholar
- Carlier T, Willowson K, Fourkal E, Bailey D, Doss M, Conti M. 90Y PET imaging: exploring limitations and accuracy under conditions of low counts and high random fraction. Med Phys. 2015;42(7):4295–309.View ArticlePubMedGoogle Scholar
- van Elmbt L, Vandenberghe S, Walrand S, Pauwels S, Jamar F. Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy. Phys Med Biol. 2011;56:6759–77.View ArticlePubMedGoogle Scholar
- Attarwala AA, Molina-Duran F, Busing KA, Schonberg SO, Bailey DL, Willowson K, Glatting G. Quantitative and qualitative assessment of yttrium-90 PET/CT imaging. PLoS One. 2014;9:e110401.View ArticlePubMedPubMed CentralGoogle Scholar
- Willowson KP, Bailey DL, Tapner M, the QUEST Investigator Team. A multi-centre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization. Eur J Nucl Med Mol Imaging. 2015;42:1202–22.View ArticlePubMedPubMed CentralGoogle Scholar